Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammary Glands, Animal | 86 | 2022 | 482 | 11.500 |
Why?
|
Breast Neoplasms | 50 | 2024 | 2480 | 5.320 |
Why?
|
Neoplastic Stem Cells | 24 | 2023 | 295 | 5.150 |
Why?
|
Triple Negative Breast Neoplasms | 12 | 2024 | 219 | 4.950 |
Why?
|
Mammary Neoplasms, Animal | 15 | 2021 | 138 | 3.770 |
Why?
|
Mammary Glands, Human | 13 | 2014 | 80 | 3.560 |
Why?
|
Stem Cells | 18 | 2017 | 710 | 3.350 |
Why?
|
Epithelial Cells | 36 | 2022 | 907 | 3.250 |
Why?
|
Caseins | 39 | 2011 | 62 | 2.960 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 13 | 2018 | 66 | 2.900 |
Why?
|
Mammary Neoplasms, Experimental | 24 | 2015 | 245 | 2.590 |
Why?
|
Breast | 10 | 2022 | 214 | 2.450 |
Why?
|
Tumor Microenvironment | 14 | 2024 | 548 | 2.430 |
Why?
|
Mice | 127 | 2024 | 17568 | 2.340 |
Why?
|
Animals | 185 | 2024 | 33755 | 2.310 |
Why?
|
Gene Expression Regulation, Neoplastic | 23 | 2023 | 1890 | 2.230 |
Why?
|
RNA, Long Noncoding | 5 | 2023 | 210 | 1.880 |
Why?
|
Cell Differentiation | 20 | 2020 | 1935 | 1.870 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 8 | 2020 | 37 | 1.870 |
Why?
|
Wnt Signaling Pathway | 10 | 2022 | 200 | 1.750 |
Why?
|
Signal Transduction | 31 | 2022 | 4511 | 1.740 |
Why?
|
Milk Proteins | 20 | 2007 | 90 | 1.730 |
Why?
|
MicroRNAs | 9 | 2021 | 839 | 1.690 |
Why?
|
Epithelial-Mesenchymal Transition | 9 | 2022 | 218 | 1.670 |
Why?
|
Prolactin | 18 | 2011 | 104 | 1.490 |
Why?
|
Cell Transformation, Neoplastic | 17 | 2022 | 630 | 1.480 |
Why?
|
Wnt Proteins | 7 | 2013 | 201 | 1.390 |
Why?
|
Protein Kinases | 6 | 2011 | 329 | 1.380 |
Why?
|
DNA Damage | 10 | 2020 | 517 | 1.290 |
Why?
|
Single-Cell Analysis | 2 | 2022 | 259 | 1.290 |
Why?
|
Neoplasm Metastasis | 9 | 2024 | 650 | 1.250 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 3 | 2022 | 36 | 1.250 |
Why?
|
Radiation Tolerance | 4 | 2010 | 53 | 1.250 |
Why?
|
RNA, Untranslated | 5 | 2012 | 114 | 1.240 |
Why?
|
beta Catenin | 10 | 2023 | 208 | 1.200 |
Why?
|
Myeloid-Derived Suppressor Cells | 6 | 2021 | 49 | 1.190 |
Why?
|
Female | 137 | 2024 | 64958 | 1.190 |
Why?
|
GTPase-Activating Proteins | 6 | 2011 | 85 | 1.180 |
Why?
|
Ecosystem | 3 | 2023 | 76 | 1.160 |
Why?
|
Antineoplastic Agents | 6 | 2024 | 1680 | 1.150 |
Why?
|
RNA, Messenger | 39 | 2020 | 2829 | 1.140 |
Why?
|
Mesoderm | 6 | 2021 | 117 | 1.110 |
Why?
|
Tumor Suppressor Protein p53 | 11 | 2017 | 713 | 1.100 |
Why?
|
Cell Proliferation | 20 | 2024 | 2313 | 1.090 |
Why?
|
Gene Expression Profiling | 17 | 2016 | 1674 | 1.080 |
Why?
|
STAT5 Transcription Factor | 14 | 2022 | 89 | 1.070 |
Why?
|
Cell Line, Tumor | 25 | 2024 | 3293 | 1.060 |
Why?
|
Adenocarcinoma | 10 | 2023 | 1001 | 1.020 |
Why?
|
Macrophages | 6 | 2022 | 611 | 1.010 |
Why?
|
Receptors, Progesterone | 11 | 2015 | 865 | 1.010 |
Why?
|
Homeostasis | 4 | 2017 | 680 | 0.970 |
Why?
|
CREB-Binding Protein | 1 | 2024 | 64 | 0.940 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 6 | 2014 | 35 | 0.930 |
Why?
|
Carcinoma | 2 | 2020 | 282 | 0.910 |
Why?
|
Cell Lineage | 7 | 2017 | 348 | 0.900 |
Why?
|
Cell Self Renewal | 3 | 2018 | 41 | 0.880 |
Why?
|
Gene Expression Regulation, Developmental | 11 | 2014 | 1003 | 0.840 |
Why?
|
Epithelium | 15 | 2015 | 373 | 0.840 |
Why?
|
Neutrophils | 2 | 2024 | 372 | 0.830 |
Why?
|
Neoplasms | 10 | 2023 | 2753 | 0.830 |
Why?
|
Trans-Activators | 10 | 2016 | 804 | 0.810 |
Why?
|
Mice, Inbred BALB C | 15 | 2021 | 980 | 0.810 |
Why?
|
Humans | 99 | 2024 | 122432 | 0.800 |
Why?
|
Progesterone | 10 | 2015 | 624 | 0.790 |
Why?
|
Mice, Knockout | 18 | 2020 | 3773 | 0.790 |
Why?
|
Estrogens | 7 | 2015 | 506 | 0.780 |
Why?
|
Repressor Proteins | 6 | 2014 | 812 | 0.780 |
Why?
|
Biomarkers, Tumor | 6 | 2020 | 1424 | 0.780 |
Why?
|
Disease Models, Animal | 14 | 2024 | 4285 | 0.770 |
Why?
|
Wnt1 Protein | 5 | 2019 | 71 | 0.750 |
Why?
|
5' Untranslated Regions | 2 | 2018 | 59 | 0.750 |
Why?
|
Mammary Tumor Virus, Mouse | 8 | 2019 | 106 | 0.750 |
Why?
|
Receptors, Glucocorticoid | 7 | 2011 | 123 | 0.740 |
Why?
|
ErbB Receptors | 4 | 2019 | 282 | 0.730 |
Why?
|
Cell Division | 14 | 2015 | 796 | 0.730 |
Why?
|
Claudins | 6 | 2022 | 29 | 0.720 |
Why?
|
Mice, Transgenic | 24 | 2017 | 2440 | 0.720 |
Why?
|
Apoptosis | 13 | 2021 | 1791 | 0.710 |
Why?
|
Transcription, Genetic | 20 | 2020 | 1703 | 0.700 |
Why?
|
Protein Biosynthesis | 11 | 2018 | 669 | 0.700 |
Why?
|
Paracrine Communication | 4 | 2015 | 71 | 0.680 |
Why?
|
Epigenesis, Genetic | 4 | 2021 | 666 | 0.670 |
Why?
|
Spindle Apparatus | 3 | 2015 | 60 | 0.660 |
Why?
|
Chromosome Segregation | 2 | 2009 | 58 | 0.650 |
Why?
|
Stromal Cells | 4 | 2015 | 296 | 0.640 |
Why?
|
Cell Polarity | 4 | 2016 | 124 | 0.640 |
Why?
|
Gene Expression Regulation | 15 | 2012 | 2535 | 0.640 |
Why?
|
Organoids | 1 | 2021 | 276 | 0.620 |
Why?
|
Eukaryotic Initiation Factor-4A | 1 | 2018 | 10 | 0.620 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2020 | 551 | 0.610 |
Why?
|
Neoplasm Proteins | 7 | 2021 | 670 | 0.610 |
Why?
|
DNA-Binding Proteins | 12 | 2020 | 2042 | 0.610 |
Why?
|
Dishevelled Proteins | 2 | 2017 | 43 | 0.600 |
Why?
|
Forkhead Box Protein O1 | 1 | 2017 | 95 | 0.580 |
Why?
|
Cell Movement | 5 | 2020 | 839 | 0.570 |
Why?
|
rho-Associated Kinases | 1 | 2017 | 55 | 0.560 |
Why?
|
Estrogen Receptor Modulators | 1 | 2017 | 38 | 0.560 |
Why?
|
Cell Separation | 7 | 2019 | 237 | 0.560 |
Why?
|
Receptors, Estrogen | 7 | 2015 | 788 | 0.550 |
Why?
|
DNA Repair | 4 | 2015 | 584 | 0.550 |
Why?
|
rho GTP-Binding Proteins | 1 | 2017 | 68 | 0.550 |
Why?
|
Genetic Heterogeneity | 1 | 2017 | 124 | 0.540 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2022 | 1118 | 0.530 |
Why?
|
Antigens, Ly | 3 | 2011 | 32 | 0.530 |
Why?
|
PTEN Phosphohydrolase | 2 | 2015 | 263 | 0.520 |
Why?
|
Carboplatin | 2 | 2015 | 78 | 0.510 |
Why?
|
Immunotherapy | 2 | 2019 | 658 | 0.510 |
Why?
|
Rats | 35 | 2012 | 3658 | 0.500 |
Why?
|
Models, Biological | 11 | 2020 | 1438 | 0.500 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2024 | 875 | 0.490 |
Why?
|
Actin Cytoskeleton | 1 | 2015 | 43 | 0.490 |
Why?
|
Cell Adhesion | 6 | 2022 | 321 | 0.480 |
Why?
|
Pregnancy | 31 | 2015 | 7094 | 0.470 |
Why?
|
Doxorubicin | 2 | 2015 | 307 | 0.460 |
Why?
|
Hormones | 7 | 2010 | 189 | 0.460 |
Why?
|
Receptors, Notch | 3 | 2015 | 206 | 0.440 |
Why?
|
Phosphoproteins | 5 | 2016 | 401 | 0.430 |
Why?
|
Up-Regulation | 2 | 2015 | 873 | 0.430 |
Why?
|
Base Sequence | 25 | 2011 | 3113 | 0.420 |
Why?
|
Protein Kinase Inhibitors | 3 | 2019 | 525 | 0.420 |
Why?
|
Retinoblastoma-Binding Protein 7 | 1 | 2012 | 6 | 0.420 |
Why?
|
YY1 Transcription Factor | 2 | 2009 | 12 | 0.400 |
Why?
|
T-Lymphocytes | 1 | 2020 | 1678 | 0.400 |
Why?
|
Oncogenes | 5 | 2015 | 172 | 0.400 |
Why?
|
Checkpoint Kinase 1 | 6 | 2011 | 25 | 0.390 |
Why?
|
Transcription Factors | 7 | 2020 | 2587 | 0.390 |
Why?
|
Oligonucleotide Array Sequence Analysis | 8 | 2013 | 1000 | 0.380 |
Why?
|
Haplotypes | 2 | 2010 | 512 | 0.370 |
Why?
|
Neoplasm Transplantation | 7 | 2014 | 375 | 0.370 |
Why?
|
Enhancer Elements, Genetic | 4 | 2020 | 297 | 0.370 |
Why?
|
Phosphorylation | 12 | 2014 | 1614 | 0.370 |
Why?
|
Endoribonucleases | 2 | 2024 | 84 | 0.370 |
Why?
|
Nanoshells | 1 | 2010 | 13 | 0.370 |
Why?
|
cdc25 Phosphatases | 3 | 2005 | 22 | 0.370 |
Why?
|
Neoplasms, Experimental | 2 | 2011 | 215 | 0.360 |
Why?
|
Genes, Tumor Suppressor | 4 | 2021 | 204 | 0.360 |
Why?
|
Hyperthermia, Induced | 1 | 2010 | 45 | 0.360 |
Why?
|
Gold | 1 | 2010 | 50 | 0.350 |
Why?
|
Membrane Proteins | 5 | 2011 | 1526 | 0.350 |
Why?
|
Erythropoiesis | 1 | 2010 | 40 | 0.340 |
Why?
|
DNA Replication | 2 | 2009 | 345 | 0.340 |
Why?
|
Mice, SCID | 6 | 2014 | 571 | 0.330 |
Why?
|
Oncogene Proteins | 1 | 2010 | 140 | 0.330 |
Why?
|
Cell Transdifferentiation | 1 | 2010 | 67 | 0.330 |
Why?
|
Biology | 1 | 2009 | 28 | 0.330 |
Why?
|
Myeloid Cells | 3 | 2019 | 100 | 0.330 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2011 | 1296 | 0.330 |
Why?
|
Cytokinesis | 1 | 2009 | 27 | 0.330 |
Why?
|
Receptors, Fibroblast Growth Factor | 4 | 2003 | 60 | 0.320 |
Why?
|
Protein Isoforms | 4 | 2020 | 409 | 0.320 |
Why?
|
Cell Line | 12 | 2020 | 2786 | 0.320 |
Why?
|
Genomic Instability | 2 | 2011 | 230 | 0.320 |
Why?
|
NFI Transcription Factors | 2 | 2007 | 50 | 0.320 |
Why?
|
Mice, Inbred C57BL | 12 | 2020 | 4367 | 0.320 |
Why?
|
Aging | 1 | 2015 | 1165 | 0.310 |
Why?
|
Histone Deacetylases | 1 | 2009 | 115 | 0.310 |
Why?
|
Cell Cycle | 6 | 2016 | 619 | 0.310 |
Why?
|
Osteosarcoma | 1 | 2011 | 258 | 0.310 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2003 | 133 | 0.310 |
Why?
|
Gonadal Steroid Hormones | 1 | 2008 | 84 | 0.300 |
Why?
|
Disease Progression | 8 | 2019 | 1990 | 0.300 |
Why?
|
Lactation | 13 | 2015 | 185 | 0.300 |
Why?
|
Cells, Cultured | 8 | 2014 | 3075 | 0.290 |
Why?
|
Promoter Regions, Genetic | 8 | 2013 | 1354 | 0.290 |
Why?
|
Pyrimidines | 3 | 2021 | 376 | 0.290 |
Why?
|
Transfection | 8 | 2018 | 1076 | 0.290 |
Why?
|
Morphogenesis | 4 | 2015 | 212 | 0.290 |
Why?
|
Integrases | 4 | 2015 | 162 | 0.280 |
Why?
|
Keratins | 2 | 2006 | 55 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 493 | 0.280 |
Why?
|
RNA, Double-Stranded | 2 | 2024 | 63 | 0.280 |
Why?
|
Receptor, IGF Type 1 | 1 | 2007 | 91 | 0.280 |
Why?
|
Cyclin D1 | 2 | 2005 | 116 | 0.280 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2010 | 120 | 0.270 |
Why?
|
Estrogen Receptor alpha | 2 | 2010 | 444 | 0.270 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 282 | 0.270 |
Why?
|
Glucocorticoids | 1 | 2009 | 379 | 0.270 |
Why?
|
Neoplasm, Residual | 2 | 2022 | 122 | 0.270 |
Why?
|
DNA | 16 | 1996 | 1608 | 0.270 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2006 | 93 | 0.270 |
Why?
|
Transforming Growth Factor beta | 2 | 2006 | 460 | 0.270 |
Why?
|
Cell Cycle Proteins | 3 | 2014 | 660 | 0.260 |
Why?
|
Anemia | 1 | 2010 | 338 | 0.260 |
Why?
|
Flow Cytometry | 8 | 2019 | 810 | 0.260 |
Why?
|
Precancerous Conditions | 2 | 2006 | 287 | 0.260 |
Why?
|
Genes | 9 | 1986 | 443 | 0.250 |
Why?
|
Animals, Genetically Modified | 3 | 2013 | 316 | 0.250 |
Why?
|
Sexual Maturation | 2 | 2016 | 48 | 0.250 |
Why?
|
Dimerization | 5 | 2006 | 144 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2016 | 429 | 0.240 |
Why?
|
Pyroptosis | 1 | 2024 | 20 | 0.240 |
Why?
|
RNA, Small Interfering | 5 | 2011 | 663 | 0.240 |
Why?
|
Taxoids | 1 | 2024 | 67 | 0.240 |
Why?
|
Neoplasms, Hormone-Dependent | 4 | 2015 | 98 | 0.240 |
Why?
|
Glycoproteins | 1 | 2007 | 371 | 0.230 |
Why?
|
E1A-Associated p300 Protein | 1 | 2024 | 54 | 0.230 |
Why?
|
Keratin-8 | 2 | 2015 | 11 | 0.230 |
Why?
|
RNA Splicing | 4 | 2021 | 224 | 0.230 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2021 | 97 | 0.230 |
Why?
|
Tumor Suppressor Proteins | 5 | 2012 | 469 | 0.230 |
Why?
|
Receptors, Prolactin | 2 | 2002 | 11 | 0.230 |
Why?
|
Molecular Targeted Therapy | 3 | 2021 | 352 | 0.220 |
Why?
|
Cell Size | 3 | 2016 | 81 | 0.220 |
Why?
|
Genomics | 1 | 2011 | 1472 | 0.220 |
Why?
|
Down-Regulation | 4 | 2015 | 702 | 0.220 |
Why?
|
Carcinogenesis | 5 | 2019 | 332 | 0.220 |
Why?
|
Somatomedins | 1 | 2003 | 36 | 0.220 |
Why?
|
Interferons | 1 | 2023 | 121 | 0.210 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2021 | 70 | 0.210 |
Why?
|
Protein Binding | 3 | 2020 | 1733 | 0.210 |
Why?
|
src-Family Kinases | 1 | 2003 | 83 | 0.210 |
Why?
|
Cytoskeletal Proteins | 2 | 2003 | 270 | 0.210 |
Why?
|
Mitosis | 5 | 2020 | 239 | 0.200 |
Why?
|
Recombinant Proteins | 4 | 2006 | 1370 | 0.200 |
Why?
|
Transgenes | 5 | 2012 | 330 | 0.200 |
Why?
|
Transplantation, Heterologous | 3 | 2011 | 257 | 0.200 |
Why?
|
Jagged-1 Protein | 1 | 2022 | 52 | 0.200 |
Why?
|
Heterozygote | 3 | 2011 | 681 | 0.200 |
Why?
|
Plasmids | 9 | 2005 | 516 | 0.200 |
Why?
|
Natural Killer T-Cells | 1 | 2023 | 77 | 0.200 |
Why?
|
Nucleic Acid Hybridization | 18 | 1985 | 397 | 0.200 |
Why?
|
Phenotype | 8 | 2019 | 4214 | 0.200 |
Why?
|
Puberty | 2 | 2015 | 94 | 0.200 |
Why?
|
Cyclophosphamide | 2 | 2022 | 422 | 0.200 |
Why?
|
Nuclear Proteins | 3 | 2003 | 1283 | 0.190 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-5 | 2 | 2012 | 10 | 0.190 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2015 | 717 | 0.190 |
Why?
|
Azacitidine | 1 | 2021 | 56 | 0.190 |
Why?
|
Disease Susceptibility | 2 | 2020 | 298 | 0.190 |
Why?
|
Ribosomes | 3 | 2018 | 138 | 0.190 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 10 | 2001 | 56 | 0.190 |
Why?
|
CD4 Antigens | 1 | 2021 | 56 | 0.190 |
Why?
|
Platelet Factor 4 | 1 | 2021 | 22 | 0.190 |
Why?
|
Muscle Proteins | 1 | 2004 | 416 | 0.190 |
Why?
|
RNA Processing, Post-Transcriptional | 2 | 2020 | 76 | 0.190 |
Why?
|
Dual-Specificity Phosphatases | 2 | 2011 | 23 | 0.190 |
Why?
|
Leukemia | 1 | 2004 | 375 | 0.190 |
Why?
|
CD8 Antigens | 1 | 2021 | 43 | 0.190 |
Why?
|
Genes, p53 | 4 | 2010 | 215 | 0.190 |
Why?
|
Benzamides | 1 | 2021 | 108 | 0.180 |
Why?
|
Databases, Genetic | 1 | 2003 | 469 | 0.180 |
Why?
|
Spliceosomes | 1 | 2021 | 48 | 0.180 |
Why?
|
Blotting, Western | 4 | 2011 | 1104 | 0.180 |
Why?
|
Receptors, Thrombopoietin | 1 | 2020 | 31 | 0.180 |
Why?
|
Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 22 | 0.180 |
Why?
|
Lung Neoplasms | 2 | 2021 | 1614 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2021 | 187 | 0.180 |
Why?
|
Carrier Proteins | 1 | 2006 | 1020 | 0.180 |
Why?
|
Stem Cell Niche | 1 | 2020 | 54 | 0.180 |
Why?
|
Short Interspersed Nucleotide Elements | 1 | 2020 | 19 | 0.180 |
Why?
|
DNA Transposable Elements | 2 | 2020 | 179 | 0.180 |
Why?
|
Biomarkers | 4 | 2021 | 2933 | 0.180 |
Why?
|
Insulin Receptor Substrate Proteins | 3 | 2007 | 78 | 0.180 |
Why?
|
Cell Survival | 4 | 2009 | 816 | 0.180 |
Why?
|
Receptor, ErbB-2 | 4 | 2010 | 497 | 0.170 |
Why?
|
Small Molecule Libraries | 1 | 2021 | 123 | 0.170 |
Why?
|
Heterografts | 3 | 2015 | 184 | 0.170 |
Why?
|
Immunoenzyme Techniques | 3 | 2010 | 268 | 0.170 |
Why?
|
Proto-Oncogene Proteins | 5 | 2014 | 559 | 0.170 |
Why?
|
Transplants | 1 | 2020 | 36 | 0.170 |
Why?
|
Immunity | 1 | 2021 | 182 | 0.170 |
Why?
|
RNA Stability | 1 | 2020 | 85 | 0.170 |
Why?
|
Organogenesis | 2 | 2010 | 78 | 0.170 |
Why?
|
Proteostasis | 1 | 2020 | 35 | 0.170 |
Why?
|
Chromatin | 4 | 2011 | 552 | 0.170 |
Why?
|
Aurora Kinase B | 2 | 2009 | 8 | 0.170 |
Why?
|
Sequence Analysis, DNA | 3 | 2013 | 1758 | 0.170 |
Why?
|
Transcriptional Activation | 5 | 2011 | 483 | 0.170 |
Why?
|
Aurora Kinases | 2 | 2009 | 31 | 0.170 |
Why?
|
Recombinant Fusion Proteins | 5 | 2007 | 768 | 0.170 |
Why?
|
Endoplasmic Reticulum | 1 | 2020 | 213 | 0.170 |
Why?
|
DNA Primers | 3 | 2011 | 668 | 0.170 |
Why?
|
rhoA GTP-Binding Protein | 2 | 2017 | 44 | 0.170 |
Why?
|
B-Lymphocytes | 1 | 2022 | 518 | 0.160 |
Why?
|
Colony-Forming Units Assay | 2 | 2010 | 70 | 0.160 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2022 | 506 | 0.160 |
Why?
|
Gene Expression | 6 | 2013 | 1580 | 0.160 |
Why?
|
Estradiol | 6 | 2002 | 534 | 0.160 |
Why?
|
Mice, Nude | 3 | 2021 | 697 | 0.160 |
Why?
|
Quinazolines | 3 | 2015 | 176 | 0.160 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2019 | 58 | 0.160 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 285 | 0.160 |
Why?
|
Mice, Mutant Strains | 2 | 2010 | 388 | 0.160 |
Why?
|
Cattle | 5 | 2006 | 555 | 0.160 |
Why?
|
Zebrafish Proteins | 2 | 2003 | 105 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 570 | 0.160 |
Why?
|
Tyrosine | 1 | 1999 | 167 | 0.160 |
Why?
|
Fluorescent Antibody Technique | 4 | 2010 | 461 | 0.160 |
Why?
|
Triterpenes | 1 | 2018 | 21 | 0.150 |
Why?
|
Fibroblast Growth Factors | 2 | 2003 | 153 | 0.150 |
Why?
|
Chromosomes, Artificial, Bacterial | 2 | 2012 | 93 | 0.150 |
Why?
|
Pregnancy Complications | 1 | 2003 | 503 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 398 | 0.150 |
Why?
|
Homozygote | 2 | 2011 | 534 | 0.150 |
Why?
|
Spheroids, Cellular | 3 | 2014 | 59 | 0.150 |
Why?
|
X-Box Binding Protein 1 | 1 | 2018 | 29 | 0.150 |
Why?
|
Reproducibility of Results | 3 | 2021 | 2797 | 0.150 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 2017 | 20 | 0.150 |
Why?
|
Response Elements | 1 | 2018 | 99 | 0.150 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 347 | 0.150 |
Why?
|
RNA Helicases | 1 | 2018 | 63 | 0.150 |
Why?
|
Gene Knockout Techniques | 2 | 2021 | 127 | 0.150 |
Why?
|
Lentivirus | 3 | 2014 | 84 | 0.150 |
Why?
|
Hydrocortisone | 9 | 2011 | 215 | 0.150 |
Why?
|
Receptors, Steroid | 2 | 2011 | 269 | 0.150 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1998 | 167 | 0.140 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2009 | 239 | 0.140 |
Why?
|
In Situ Hybridization | 2 | 2011 | 474 | 0.140 |
Why?
|
Molecular Sequence Data | 6 | 2012 | 3869 | 0.140 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 181 | 0.140 |
Why?
|
Genetic Vectors | 4 | 2014 | 969 | 0.140 |
Why?
|
Collagen | 2 | 2015 | 312 | 0.140 |
Why?
|
Cell Culture Techniques | 2 | 2009 | 288 | 0.140 |
Why?
|
Tamoxifen | 2 | 2015 | 363 | 0.140 |
Why?
|
Cluster Analysis | 3 | 2013 | 386 | 0.130 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 541 | 0.130 |
Why?
|
Stem Cell Transplantation | 2 | 2015 | 239 | 0.130 |
Why?
|
Oviducts | 8 | 1977 | 330 | 0.130 |
Why?
|
Tenascin | 1 | 2015 | 35 | 0.130 |
Why?
|
Polyribosomes | 2 | 2010 | 25 | 0.130 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 351 | 0.130 |
Why?
|
CD24 Antigen | 3 | 2013 | 30 | 0.130 |
Why?
|
Phenylurea Compounds | 1 | 2015 | 48 | 0.130 |
Why?
|
Sialoglycoproteins | 2 | 2006 | 48 | 0.120 |
Why?
|
Cloning, Molecular | 6 | 1986 | 887 | 0.120 |
Why?
|
Enzyme Activation | 4 | 2020 | 621 | 0.120 |
Why?
|
Cell Line, Transformed | 3 | 2013 | 172 | 0.120 |
Why?
|
Cell Shape | 1 | 2015 | 61 | 0.120 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 139 | 0.120 |
Why?
|
Integrin beta1 | 3 | 2013 | 54 | 0.120 |
Why?
|
Cellular Senescence | 3 | 2011 | 159 | 0.120 |
Why?
|
Antigens, Surface | 1 | 2015 | 122 | 0.120 |
Why?
|
Hyperplasia | 3 | 2016 | 214 | 0.120 |
Why?
|
Protein Multimerization | 2 | 2012 | 121 | 0.120 |
Why?
|
Organ Specificity | 1 | 2015 | 427 | 0.120 |
Why?
|
Coculture Techniques | 1 | 2015 | 235 | 0.120 |
Why?
|
Amino Acid Sequence | 7 | 2012 | 2680 | 0.120 |
Why?
|
RNA Interference | 3 | 2011 | 496 | 0.120 |
Why?
|
Immunophenotyping | 1 | 2015 | 333 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 1250 | 0.110 |
Why?
|
Blood Vessels | 1 | 2014 | 102 | 0.110 |
Why?
|
Structure-Activity Relationship | 3 | 2012 | 571 | 0.110 |
Why?
|
Osteogenesis | 1 | 2015 | 154 | 0.110 |
Why?
|
HEK293 Cells | 2 | 2017 | 745 | 0.110 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 10 | 0.110 |
Why?
|
Biological Evolution | 3 | 1986 | 221 | 0.110 |
Why?
|
Neovascularization, Pathologic | 3 | 2010 | 240 | 0.110 |
Why?
|
DNA Copy Number Variations | 3 | 2016 | 943 | 0.110 |
Why?
|
Protein Structure, Tertiary | 2 | 2007 | 751 | 0.110 |
Why?
|
Histones | 3 | 2010 | 530 | 0.110 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 369 | 0.110 |
Why?
|
Precision Medicine | 1 | 2016 | 307 | 0.110 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2005 | 108 | 0.100 |
Why?
|
Lactalbumin | 3 | 1981 | 11 | 0.100 |
Why?
|
Polycomb-Group Proteins | 1 | 2012 | 18 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 217 | 0.100 |
Why?
|
Chromosome Mapping | 1 | 2015 | 1067 | 0.100 |
Why?
|
COS Cells | 3 | 2006 | 273 | 0.100 |
Why?
|
Tacrolimus | 2 | 2003 | 98 | 0.100 |
Why?
|
Gene Silencing | 1 | 2013 | 236 | 0.100 |
Why?
|
Collagen Type IV | 1 | 2011 | 20 | 0.100 |
Why?
|
Endoplasmic Reticulum Stress | 2 | 2024 | 122 | 0.100 |
Why?
|
Luminescent Measurements | 1 | 2011 | 57 | 0.100 |
Why?
|
Organic Chemicals | 1 | 2011 | 59 | 0.100 |
Why?
|
Fibronectins | 1 | 2011 | 104 | 0.100 |
Why?
|
RNA, Neoplasm | 3 | 1981 | 138 | 0.100 |
Why?
|
Collagen Type I | 1 | 2011 | 110 | 0.100 |
Why?
|
Poly A | 6 | 1986 | 60 | 0.090 |
Why?
|
Multipotent Stem Cells | 1 | 2011 | 29 | 0.090 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2010 | 9 | 0.090 |
Why?
|
DNA, Recombinant | 2 | 1981 | 105 | 0.090 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2010 | 12 | 0.090 |
Why?
|
Aging, Premature | 1 | 2011 | 32 | 0.090 |
Why?
|
Cell Nucleolus | 1 | 2011 | 56 | 0.090 |
Why?
|
Radiation, Ionizing | 1 | 2010 | 42 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2011 | 79 | 0.090 |
Why?
|
Chromosomes | 2 | 2009 | 199 | 0.090 |
Why?
|
Genetic Techniques | 1 | 2011 | 102 | 0.090 |
Why?
|
Prostatic Neoplasms | 3 | 2003 | 1516 | 0.090 |
Why?
|
Rats, Inbred Strains | 7 | 1985 | 229 | 0.090 |
Why?
|
Green Fluorescent Proteins | 4 | 2014 | 391 | 0.090 |
Why?
|
Cadherins | 2 | 2015 | 164 | 0.090 |
Why?
|
Bone Neoplasms | 1 | 2015 | 428 | 0.090 |
Why?
|
Cell Dedifferentiation | 1 | 2010 | 21 | 0.090 |
Why?
|
Cell Compartmentation | 1 | 2010 | 42 | 0.090 |
Why?
|
Phosphorylcholine | 1 | 2010 | 26 | 0.090 |
Why?
|
Antigens, Differentiation | 1 | 2010 | 63 | 0.090 |
Why?
|
Gene Transfer Techniques | 1 | 2012 | 374 | 0.090 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 261 | 0.090 |
Why?
|
Cell Communication | 2 | 2011 | 165 | 0.090 |
Why?
|
Kinetics | 9 | 2016 | 1315 | 0.090 |
Why?
|
Embryo, Mammalian | 2 | 2011 | 453 | 0.090 |
Why?
|
Staurosporine | 2 | 2011 | 21 | 0.080 |
Why?
|
Immunoblotting | 2 | 2011 | 312 | 0.080 |
Why?
|
Microscopy, Confocal | 2 | 2014 | 347 | 0.080 |
Why?
|
Mutation | 5 | 2017 | 5776 | 0.080 |
Why?
|
Pregnancy, Animal | 2 | 2001 | 74 | 0.080 |
Why?
|
Thrombospondin 1 | 1 | 2009 | 22 | 0.080 |
Why?
|
Immunoprecipitation | 2 | 2011 | 197 | 0.080 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2010 | 125 | 0.080 |
Why?
|
Cytoplasm | 2 | 2021 | 291 | 0.080 |
Why?
|
Crosses, Genetic | 1 | 2009 | 160 | 0.080 |
Why?
|
In Vitro Techniques | 5 | 2007 | 968 | 0.080 |
Why?
|
DNA, Complementary | 2 | 2011 | 459 | 0.080 |
Why?
|
Mammals | 2 | 2006 | 263 | 0.080 |
Why?
|
Cell Death | 1 | 2010 | 241 | 0.080 |
Why?
|
Genome, Human | 2 | 2017 | 1257 | 0.080 |
Why?
|
Carcinoma, Ductal | 1 | 2009 | 8 | 0.080 |
Why?
|
Mice, Inbred Strains | 3 | 2006 | 317 | 0.080 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2009 | 37 | 0.080 |
Why?
|
Gene Amplification | 3 | 2021 | 228 | 0.080 |
Why?
|
Osteopontin | 2 | 2006 | 49 | 0.080 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 609 | 0.080 |
Why?
|
HeLa Cells | 3 | 2011 | 808 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2009 | 1592 | 0.080 |
Why?
|
Cyclin E | 2 | 2005 | 30 | 0.080 |
Why?
|
Genes, ras | 2 | 2019 | 96 | 0.080 |
Why?
|
Multigene Family | 2 | 2003 | 299 | 0.080 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2011 | 287 | 0.080 |
Why?
|
Nucleotidyltransferases | 1 | 2008 | 45 | 0.080 |
Why?
|
Cell Transplantation | 1 | 2008 | 54 | 0.080 |
Why?
|
Carcinoma in Situ | 1 | 2009 | 69 | 0.080 |
Why?
|
Genes, Reporter | 3 | 2014 | 385 | 0.080 |
Why?
|
Cell Count | 2 | 2020 | 250 | 0.080 |
Why?
|
Ovalbumin | 5 | 1977 | 316 | 0.080 |
Why?
|
Cell-Matrix Junctions | 2 | 2022 | 8 | 0.080 |
Why?
|
Neovascularization, Physiologic | 2 | 2006 | 209 | 0.070 |
Why?
|
Diethylstilbestrol | 4 | 1975 | 142 | 0.070 |
Why?
|
History, 20th Century | 1 | 2009 | 384 | 0.070 |
Why?
|
Acetylglucosamine | 1 | 2007 | 6 | 0.070 |
Why?
|
Transcriptome | 1 | 2013 | 904 | 0.070 |
Why?
|
Ovary | 1 | 2010 | 390 | 0.070 |
Why?
|
Computational Biology | 3 | 2017 | 794 | 0.070 |
Why?
|
Threonine | 1 | 2007 | 60 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2007 | 9 | 0.070 |
Why?
|
EGF Family of Proteins | 1 | 2007 | 12 | 0.070 |
Why?
|
Amphiregulin | 1 | 2007 | 12 | 0.070 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2007 | 37 | 0.070 |
Why?
|
Glycosylation | 1 | 2007 | 111 | 0.070 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2007 | 43 | 0.070 |
Why?
|
Organ Culture Techniques | 6 | 2002 | 155 | 0.070 |
Why?
|
Keratin-6 | 1 | 2006 | 13 | 0.070 |
Why?
|
Acetylcysteine | 1 | 2007 | 74 | 0.070 |
Why?
|
Serpins | 1 | 2006 | 27 | 0.070 |
Why?
|
Nucleic Acid Precursors | 1 | 1986 | 16 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2012 | 1710 | 0.070 |
Why?
|
Survival Analysis | 2 | 2021 | 1468 | 0.070 |
Why?
|
Tumor Cells, Cultured | 3 | 2003 | 1076 | 0.070 |
Why?
|
Gene Dosage | 2 | 2020 | 441 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2008 | 326 | 0.070 |
Why?
|
Parity | 3 | 2003 | 79 | 0.070 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2005 | 16 | 0.070 |
Why?
|
RNA Polymerase II | 1 | 2006 | 100 | 0.070 |
Why?
|
Forecasting | 1 | 2007 | 355 | 0.060 |
Why?
|
Basement Membrane | 1 | 2005 | 46 | 0.060 |
Why?
|
Drug Resistance, Multiple | 1 | 2005 | 50 | 0.060 |
Why?
|
DNA, Neoplasm | 3 | 1972 | 303 | 0.060 |
Why?
|
Fibroblasts | 4 | 2019 | 881 | 0.060 |
Why?
|
Genes, Homeobox | 1 | 2005 | 70 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2007 | 280 | 0.060 |
Why?
|
Ki-67 Antigen | 1 | 2005 | 114 | 0.060 |
Why?
|
Microtubule-Associated Proteins | 1 | 2007 | 244 | 0.060 |
Why?
|
Protein Transport | 2 | 2020 | 369 | 0.060 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 1972 | 162 | 0.060 |
Why?
|
Binding Sites | 3 | 2003 | 1293 | 0.060 |
Why?
|
Bridged-Ring Compounds | 1 | 2024 | 16 | 0.060 |
Why?
|
S Phase | 1 | 2004 | 73 | 0.060 |
Why?
|
RNA | 4 | 1981 | 579 | 0.060 |
Why?
|
Species Specificity | 4 | 2015 | 550 | 0.060 |
Why?
|
MAP Kinase Signaling System | 2 | 2003 | 320 | 0.060 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2003 | 43 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2006 | 346 | 0.060 |
Why?
|
B7-H1 Antigen | 1 | 2024 | 102 | 0.060 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2024 | 112 | 0.060 |
Why?
|
Male | 10 | 2020 | 59590 | 0.060 |
Why?
|
Benz(a)Anthracenes | 1 | 1983 | 3 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2003 | 90 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 83 | 0.050 |
Why?
|
Cyclins | 1 | 2003 | 104 | 0.050 |
Why?
|
Time Factors | 6 | 2013 | 6181 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 1999 | 312 | 0.050 |
Why?
|
Prostatic Hyperplasia | 1 | 2003 | 107 | 0.050 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2023 | 12 | 0.050 |
Why?
|
Xenopus Proteins | 1 | 2003 | 60 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 8 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2005 | 352 | 0.050 |
Why?
|
Cornified Envelope Proline-Rich Proteins | 1 | 2002 | 19 | 0.050 |
Why?
|
Phosphotyrosine | 1 | 2002 | 23 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 174 | 0.050 |
Why?
|
Xenopus laevis | 1 | 2003 | 122 | 0.050 |
Why?
|
Conserved Sequence | 1 | 2003 | 292 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2003 | 156 | 0.050 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2002 | 45 | 0.050 |
Why?
|
Inflammasomes | 1 | 2024 | 149 | 0.050 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2002 | 16 | 0.050 |
Why?
|
Molecular Weight | 6 | 1986 | 390 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 654 | 0.050 |
Why?
|
Viral Proteins | 1 | 2004 | 348 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2004 | 278 | 0.050 |
Why?
|
Integrins | 1 | 2022 | 81 | 0.050 |
Why?
|
Mutagenesis | 2 | 2001 | 351 | 0.050 |
Why?
|
Protein Precursors | 1 | 2002 | 150 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2003 | 615 | 0.050 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2002 | 66 | 0.050 |
Why?
|
Wound Healing | 1 | 2005 | 454 | 0.050 |
Why?
|
Codon | 2 | 1997 | 97 | 0.050 |
Why?
|
Transplantation, Isogeneic | 1 | 2021 | 15 | 0.050 |
Why?
|
Chickens | 7 | 2010 | 637 | 0.050 |
Why?
|
Phylogeny | 1 | 2003 | 681 | 0.050 |
Why?
|
Prognosis | 1 | 2010 | 4489 | 0.050 |
Why?
|
Protein Conformation | 1 | 2003 | 833 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2002 | 213 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2003 | 1004 | 0.050 |
Why?
|
Body Patterning | 2 | 2016 | 122 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2023 | 680 | 0.050 |
Why?
|
Monitoring, Immunologic | 1 | 2020 | 17 | 0.040 |
Why?
|
Gene Regulatory Networks | 2 | 2015 | 353 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 8 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2021 | 89 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2004 | 1084 | 0.040 |
Why?
|
eIF-2 Kinase | 1 | 2020 | 37 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2003 | 670 | 0.040 |
Why?
|
Introns | 1 | 2021 | 303 | 0.040 |
Why?
|
DNA Restriction Enzymes | 4 | 1984 | 121 | 0.040 |
Why?
|
Cricetinae | 2 | 1999 | 404 | 0.040 |
Why?
|
Granulocytes | 1 | 2019 | 65 | 0.040 |
Why?
|
Half-Life | 3 | 1985 | 159 | 0.040 |
Why?
|
Lithium Chloride | 1 | 2019 | 8 | 0.040 |
Why?
|
Genetic Therapy | 1 | 2003 | 706 | 0.040 |
Why?
|
Cell Growth Processes | 2 | 2009 | 63 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2019 | 77 | 0.040 |
Why?
|
Inflammation | 1 | 2006 | 1392 | 0.040 |
Why?
|
CHO Cells | 1 | 1999 | 159 | 0.040 |
Why?
|
Datasets as Topic | 1 | 2019 | 84 | 0.040 |
Why?
|
Tritium | 7 | 1974 | 174 | 0.040 |
Why?
|
Cocarcinogenesis | 1 | 1998 | 23 | 0.040 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 326 | 0.040 |
Why?
|
Unfolded Protein Response | 1 | 2018 | 62 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1998 | 54 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2020 | 526 | 0.040 |
Why?
|
Calcium | 1 | 1982 | 1095 | 0.040 |
Why?
|
Hexoses | 3 | 1972 | 11 | 0.040 |
Why?
|
Glucose | 3 | 1972 | 876 | 0.040 |
Why?
|
Carcinogens | 1 | 1998 | 152 | 0.040 |
Why?
|
Pyrroles | 1 | 2019 | 177 | 0.040 |
Why?
|
Open Reading Frames | 1 | 2017 | 211 | 0.040 |
Why?
|
Gene Library | 1 | 2017 | 219 | 0.030 |
Why?
|
Chromosomes, Mammalian | 1 | 2016 | 42 | 0.030 |
Why?
|
Enzymes | 1 | 1996 | 51 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2016 | 98 | 0.030 |
Why?
|
Neoplasms, Basal Cell | 1 | 2015 | 7 | 0.030 |
Why?
|
Models, Anatomic | 1 | 2016 | 96 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2016 | 166 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 370 | 0.030 |
Why?
|
Centrifugation, Density Gradient | 4 | 1983 | 97 | 0.030 |
Why?
|
Models, Statistical | 1 | 2017 | 447 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2015 | 69 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2018 | 416 | 0.030 |
Why?
|
Genetic Engineering | 1 | 1996 | 159 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2015 | 1227 | 0.030 |
Why?
|
Pyridines | 1 | 2016 | 222 | 0.030 |
Why?
|
Genetic Code | 1 | 1974 | 40 | 0.030 |
Why?
|
Fluorescence | 1 | 2014 | 93 | 0.030 |
Why?
|
Cell Membrane | 2 | 2009 | 459 | 0.030 |
Why?
|
Cell Tracking | 1 | 2014 | 17 | 0.030 |
Why?
|
Regeneration | 1 | 2016 | 202 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2014 | 95 | 0.030 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 38 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1996 | 340 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 99 | 0.030 |
Why?
|
Proteolysis | 1 | 2014 | 171 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 1986 | 368 | 0.030 |
Why?
|
Erlotinib Hydrochloride | 1 | 2013 | 14 | 0.030 |
Why?
|
Pyrazoles | 1 | 2016 | 300 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2014 | 297 | 0.030 |
Why?
|
Microscopy, Electron | 3 | 1983 | 400 | 0.030 |
Why?
|
Paclitaxel | 1 | 2013 | 122 | 0.030 |
Why?
|
Leukemia L1210 | 1 | 1972 | 4 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 865 | 0.030 |
Why?
|
Cell Nucleus | 4 | 2002 | 678 | 0.030 |
Why?
|
Dexamethasone | 2 | 1970 | 274 | 0.030 |
Why?
|
Methylnitrosourea | 2 | 2001 | 19 | 0.030 |
Why?
|
Daunorubicin | 1 | 1972 | 27 | 0.030 |
Why?
|
Sodium-Potassium-Chloride Symporters | 2 | 2002 | 6 | 0.030 |
Why?
|
Axin Protein | 1 | 2012 | 17 | 0.030 |
Why?
|
Casein Kinase I | 1 | 2012 | 12 | 0.030 |
Why?
|
Intracellular Space | 1 | 2012 | 48 | 0.020 |
Why?
|
Genotyping Techniques | 1 | 2012 | 101 | 0.020 |
Why?
|
Membrane Microdomains | 1 | 2012 | 60 | 0.020 |
Why?
|
CpG Islands | 1 | 2013 | 321 | 0.020 |
Why?
|
Promegestone | 1 | 2011 | 30 | 0.020 |
Why?
|
Galactosides | 1 | 2011 | 12 | 0.020 |
Why?
|
Gene Targeting | 1 | 2012 | 177 | 0.020 |
Why?
|
Luminescence | 1 | 2011 | 15 | 0.020 |
Why?
|
Smoothened Receptor | 1 | 2011 | 28 | 0.020 |
Why?
|
Progestins | 1 | 2011 | 47 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1972 | 129 | 0.020 |
Why?
|
G2 Phase | 1 | 2011 | 45 | 0.020 |
Why?
|
Hexokinase | 1 | 1970 | 20 | 0.020 |
Why?
|
Goosecoid Protein | 1 | 2010 | 4 | 0.020 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2010 | 31 | 0.020 |
Why?
|
Snail Family Transcription Factors | 1 | 2010 | 24 | 0.020 |
Why?
|
Chromosomes, Human | 1 | 2011 | 131 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 331 | 0.020 |
Why?
|
Twist-Related Protein 1 | 1 | 2010 | 36 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2011 | 186 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2010 | 63 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2010 | 126 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2011 | 192 | 0.020 |
Why?
|
Claudin-1 | 1 | 2009 | 17 | 0.020 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 90 | 0.020 |
Why?
|
Hyaluronan Receptors | 1 | 2009 | 66 | 0.020 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2011 | 214 | 0.020 |
Why?
|
Prostate | 1 | 2012 | 422 | 0.020 |
Why?
|
Carcinoma, Lobular | 1 | 2009 | 24 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 269 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 525 | 0.020 |
Why?
|
Fertility | 1 | 2011 | 263 | 0.020 |
Why?
|
Castration | 2 | 1978 | 31 | 0.020 |
Why?
|
Nucleic Acid Conformation | 2 | 1982 | 185 | 0.020 |
Why?
|
RNA-Directed DNA Polymerase | 3 | 1976 | 46 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2010 | 479 | 0.020 |
Why?
|
Memory | 1 | 2011 | 357 | 0.020 |
Why?
|
Genotype | 1 | 1973 | 2533 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2008 | 371 | 0.020 |
Why?
|
Thymidine | 3 | 1972 | 55 | 0.020 |
Why?
|
Lymphoma | 1 | 1970 | 323 | 0.020 |
Why?
|
Biological Transport | 2 | 2002 | 347 | 0.020 |
Why?
|
Methods | 3 | 1975 | 150 | 0.020 |
Why?
|
Gene Deletion | 2 | 2002 | 799 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2014 | 12041 | 0.020 |
Why?
|
Carbon Isotopes | 3 | 1972 | 272 | 0.020 |
Why?
|
DNA Methylation | 1 | 2013 | 991 | 0.020 |
Why?
|
Moloney murine sarcoma virus | 1 | 1986 | 1 | 0.020 |
Why?
|
Triticum | 2 | 1976 | 35 | 0.020 |
Why?
|
Protein Sorting Signals | 1 | 1986 | 38 | 0.020 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2006 | 35 | 0.020 |
Why?
|
Culture Techniques | 1 | 1986 | 91 | 0.020 |
Why?
|
Temperature | 3 | 1976 | 304 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1986 | 286 | 0.020 |
Why?
|
RNA Precursors | 1 | 1986 | 67 | 0.020 |
Why?
|
Adipocytes | 1 | 2006 | 158 | 0.020 |
Why?
|
Biopsy | 1 | 2009 | 1246 | 0.020 |
Why?
|
Chromatography, Affinity | 2 | 1975 | 70 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2006 | 231 | 0.020 |
Why?
|
Escherichia coli | 2 | 1981 | 978 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2010 | 798 | 0.020 |
Why?
|
Cell-Free System | 2 | 1975 | 106 | 0.020 |
Why?
|
Research Design | 1 | 2008 | 646 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1986 | 450 | 0.010 |
Why?
|
Insulin | 2 | 1985 | 1191 | 0.010 |
Why?
|
Cyclin A | 1 | 2003 | 17 | 0.010 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2003 | 22 | 0.010 |
Why?
|
Heterochromatin | 1 | 2003 | 48 | 0.010 |
Why?
|
bcl-2-Associated X Protein | 1 | 2003 | 71 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 1986 | 356 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2003 | 51 | 0.010 |
Why?
|
Genes, myc | 1 | 2003 | 99 | 0.010 |
Why?
|
Blastula | 1 | 2003 | 1 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2003 | 79 | 0.010 |
Why?
|
Fetal Proteins | 1 | 2003 | 13 | 0.010 |
Why?
|
Gastrula | 1 | 2003 | 18 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2003 | 157 | 0.010 |
Why?
|
Microvilli | 1 | 1983 | 73 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 316 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1983 | 284 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1983 | 152 | 0.010 |
Why?
|
Models, Genetic | 1 | 1986 | 748 | 0.010 |
Why?
|
Ovariectomy | 1 | 2003 | 180 | 0.010 |
Why?
|
Nervous System | 1 | 2003 | 129 | 0.010 |
Why?
|
Depression, Chemical | 2 | 1972 | 43 | 0.010 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 1 | 1983 | 126 | 0.010 |
Why?
|
Uridine | 2 | 1972 | 34 | 0.010 |
Why?
|
Rats, Inbred WF | 1 | 2001 | 21 | 0.010 |
Why?
|
Reproductive History | 1 | 2001 | 10 | 0.010 |
Why?
|
Solute Carrier Family 12, Member 2 | 1 | 2001 | 7 | 0.010 |
Why?
|
Sheep | 1 | 1982 | 209 | 0.010 |
Why?
|
Connexins | 1 | 2001 | 56 | 0.010 |
Why?
|
DNA Nucleotidyltransferases | 2 | 1972 | 18 | 0.010 |
Why?
|
Growth Hormone | 1 | 2001 | 151 | 0.010 |
Why?
|
Transformation, Bacterial | 1 | 1981 | 11 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2001 | 122 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1983 | 471 | 0.010 |
Why?
|
Janus Kinase 2 | 1 | 2002 | 136 | 0.010 |
Why?
|
Reticulocytes | 1 | 1980 | 41 | 0.010 |
Why?
|
Adenoviridae | 1 | 2003 | 637 | 0.010 |
Why?
|
Metabolism | 2 | 1970 | 43 | 0.010 |
Why?
|
Drug Antagonism | 1 | 1980 | 13 | 0.010 |
Why?
|
Dibutyryl Cyclic GMP | 1 | 1980 | 1 | 0.010 |
Why?
|
Spermidine | 1 | 1980 | 4 | 0.010 |
Why?
|
Organ Transplantation | 1 | 2002 | 163 | 0.010 |
Why?
|
Bucladesine | 1 | 1980 | 19 | 0.010 |
Why?
|
Avian Myeloblastosis Virus | 2 | 1976 | 7 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2003 | 546 | 0.010 |
Why?
|
Cyclic GMP | 1 | 1980 | 92 | 0.010 |
Why?
|
Rabbits | 1 | 1980 | 716 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1980 | 249 | 0.010 |
Why?
|
Lactose Synthase | 1 | 1978 | 1 | 0.010 |
Why?
|
Survival Rate | 1 | 2003 | 1997 | 0.010 |
Why?
|
Steroids | 1 | 1980 | 203 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 1213 | 0.010 |
Why?
|
Nafoxidine | 1 | 1977 | 8 | 0.010 |
Why?
|
Transforming Growth Factor alpha | 1 | 1997 | 27 | 0.010 |
Why?
|
Ploidies | 1 | 1997 | 38 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2008 | 6289 | 0.010 |
Why?
|
Templates, Genetic | 1 | 1976 | 95 | 0.010 |
Why?
|
Nucleic Acid Renaturation | 2 | 1973 | 8 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1976 | 54 | 0.010 |
Why?
|
Nucleic Acid Denaturation | 2 | 1973 | 27 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 2 | 1973 | 44 | 0.010 |
Why?
|
Aneuploidy | 1 | 1997 | 156 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1980 | 1007 | 0.010 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 1975 | 18 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1975 | 59 | 0.010 |
Why?
|
Weaning | 1 | 1975 | 40 | 0.010 |
Why?
|
Micropore Filters | 1 | 1974 | 7 | 0.010 |
Why?
|
Avian Leukosis Virus | 1 | 1974 | 14 | 0.010 |
Why?
|
Borohydrides | 1 | 1973 | 2 | 0.010 |
Why?
|
Chick Embryo | 1 | 1973 | 131 | 0.010 |
Why?
|
Aminoisobutyric Acids | 1 | 1972 | 8 | 0.010 |
Why?
|
Cycloheximide | 1 | 1972 | 43 | 0.010 |
Why?
|
Sarcoma, Experimental | 1 | 1972 | 16 | 0.010 |
Why?
|
Valine | 1 | 1972 | 106 | 0.010 |
Why?
|
Hexosephosphates | 1 | 1970 | 1 | 0.010 |
Why?
|
Glucokinase | 1 | 1970 | 16 | 0.010 |
Why?
|
Glycine | 1 | 1972 | 167 | 0.010 |
Why?
|
Leucine | 1 | 1972 | 309 | 0.010 |
Why?
|
Nucleosides | 1 | 1970 | 17 | 0.010 |
Why?
|
Aged | 1 | 2008 | 18785 | 0.010 |
Why?
|
Mice, Inbred C3H | 2 | 1978 | 119 | 0.000 |
Why?
|
Middle Aged | 1 | 2008 | 25641 | 0.000 |
Why?
|
Adult | 1 | 2008 | 28757 | 0.000 |
Why?
|
Risk Factors | 1 | 2001 | 9901 | 0.000 |
Why?
|
Amino Acids | 1 | 1970 | 661 | 0.000 |
Why?
|
Testosterone | 1 | 1970 | 459 | 0.000 |
Why?
|
RNA, Viral | 2 | 1978 | 540 | 0.000 |
Why?
|
Karyotyping | 1 | 1982 | 338 | 0.000 |
Why?
|
Placental Lactogen | 1 | 1978 | 3 | 0.000 |
Why?
|
Cytarabine | 1 | 1978 | 99 | 0.000 |
Why?
|
Fibroins | 1 | 1977 | 3 | 0.000 |
Why?
|
Globins | 1 | 1977 | 35 | 0.000 |
Why?
|
DNA Viruses | 1 | 1977 | 33 | 0.000 |
Why?
|
Methylation | 1 | 1977 | 229 | 0.000 |
Why?
|
Oviposition | 1 | 1975 | 6 | 0.000 |
Why?
|
Mathematics | 1 | 1975 | 98 | 0.000 |
Why?
|
Sepharose | 1 | 1974 | 15 | 0.000 |
Why?
|
Chromatography, Gel | 1 | 1974 | 94 | 0.000 |
Why?
|
Drug Stability | 1 | 1973 | 55 | 0.000 |
Why?
|
Cytosol | 1 | 1973 | 160 | 0.000 |
Why?
|
Testis | 1 | 1974 | 407 | 0.000 |
Why?
|
Uterus | 1 | 1974 | 591 | 0.000 |
Why?
|
Liver | 1 | 1974 | 1851 | 0.000 |
Why?
|